INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 133 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2015. The put-call ratio across all filers is 2.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,605,000 | +6.2% | 98,759 | -1.4% | 0.01% | 0.0% |
| Q4 2016 | $1,512,000 | -6.9% | 100,184 | -6.0% | 0.01% | -7.7% |
| Q3 2016 | $1,624,000 | -49.0% | 106,581 | +30.0% | 0.01% | -50.0% |
| Q2 2016 | $3,183,000 | -40.9% | 81,999 | -57.6% | 0.03% | -39.5% |
| Q1 2016 | $5,382,000 | -67.6% | 193,614 | -37.3% | 0.04% | -68.6% |
| Q4 2015 | $16,605,000 | – | 308,694 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |